Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib

Clinical trial NCT06899061 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06899061
Sponsor: AstraZeneca
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Malignancies

Start date: 2025-03-25
Primary completion: 2026-02-03
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.